Here’s what’s top of mind at Vibe Bio and across the industry, by category:
Endpoint News: New US-EU trade deal will include 15% pharma tariffs, White House says
Biopharma Dive: Vinay Prasad’s ouster leaves biotech guessing at FDA direction
Fierce Pharma: FDA taps newly appointed George Tidmarsh as acting CBER leader after Vinay Prasad exit
Endpoint News: Senate confirms Susan Monarez to lead CDC and oversee reshaped vaccine advisory panel
Stat+: With $1.3 billion in hand, VC firm Frazier remains bullish on biotech
Endpoint News: Updated: AstraZeneca reports revenue growth, pipeline tweaks as it ponders price cuts, direct-to-patient sales
Fierce Biotech: Frazier Life Sciences raises $1.3B for latest early-stage biotech venture fund
Vibe Bio blog: Modern biopharma BD: How to find the diamonds in the rough
Some of biopharma’s most transformative therapies began as overlooked assets. The best business development teams go beyond spotting obvious winners: they build systems, cultivate talent, and adopt frameworks that surface and shape the “diamonds in the rough” others might miss.
Strategic clarity: Ground evaluations in a clear, long-term strategy that reflects your organization’s scientific, commercial, and operational goals.
Biology-first thinking: Start with the underlying science. Map all diseases and unmet needs tied to relevant pathways or modalities. This broader view can reveal overlooked markets and smarter partnerships.
Indication zoom-out: Regulatory paths, commercial models, and development hurdles vary greatly across indications. Gather the information relevant to your team, then tailor your approach to each.
Read the full blog for details and actionable takeaways.
We’re pretty pumped to announce the launch of our newly redesigned website!
Our new online home reflects Vibe Bio’s evolution and our commitment to transforming how the industry addresses rare and overlooked diseases: by empowering communities, driving innovation, and accelerating the journey from promising science to approved therapies. The updated site offers a clearer window into who we are, our platform technologies, and the funds we’re investing in to reshape biotech.
Our mission: To help biotechs turn breakthroughs into treatments patients actually receive.
Explore the story behind Vibe Bio, the impact we strive for, and real-world insights into biopharma business development from industry experts.
Our AI-powered due diligence platform, VibeOne, leverages AI to make search & eval easier. It does this by:
Mapping and targeting the global drug landscape in real time
Identifying and tracking high-potential assets that might otherwise be missed
Triaging the assets with the highest potential and finding differentiated programs.
Visit www.vibebio.com to find out how we’re enabling AI due diligence for therapeutics, explore the redesigned experience, meet our team, and see how we’re working to unlock cures for patients everywhere.
Industry peers continue to share candid insights as they navigate business development in a shifting landscape. For example, one biotech org recently prioritized internal AI initiatives, hiring developers to build agents across the organization. Here’s what we discovered from our conversation:
Balance speed with quality
Most individual contributors (ICs) require access to insights in near real-time, but also value the reassurance of quality assurance (QA) and a human perspective for AI-powered analysis.Real-time & human synopsis are essential
An ideal tool provides an immediate response to data requests, rapid enough for decision-making while also following up with a curated, human-generated synopsis for context and accuracy.
This type of transparent, practical feedback continues to shape how we evolve VibeOne to build the capabilities important for business development teams.
If your organization faces similar challenges or has additional insights, please reach out. We’d love to hear from you.
This month, we welcomed a new data science team member who is working hard on building new capabilities in our platform. Our move from Discord to Slack is now complete, enabling secure, scalable teamwork.
And speaking of team news: Haidee recently donated blood at a local blood drive for Boston Children’s Hospital and got a great new hat to wear! Did you know that donating blood is one of the easiest ways to help save a child’s life?
And Christina is off to race cars in Connecticut!
We believe communities spark cures — let’s stay connected as we build the future together.
Tell us what else you’d like to see in future editions of the newsletter. We’d be happy to incorporate your suggestions!
Sincerely,
The Vibe Bio Team
#EveryCureforEveryCommunity
Subscribe to our newsletter
No posts
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.